Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Souichi Iwai is active.

Publication


Featured researches published by Souichi Iwai.


Apoptosis | 2006

Induction of endonuclease G-mediated apopotosis in human oral squamous cell carcinoma cells by protein kinase C inhibitor safingol

Masakazu Hamada; Tetsurou Sumi; Souichi Iwai; Mitsuhiro Nakazawa; Yoshiaki Yura

PKC inhibitor safingol suppressed the growth of human oral squamous cell carcinoma (SCC) cells significantly at concentrations that inhibit PKC isoforms. Safingol inhibited the translocation of PKC following treatment with 12-o-tetradecanoylphorbol 13-acetate (TPA) in PKC α-EGFP-transfected cells, but not in PKC β-EGFP- transfected cells, indicating selective inhibition for PKC α in oral SCC cells. Flow cytometric analysis and DNA analysis by agarose gel electrophoresis revealed an increase in the proportion of sub-G1 cells and DNA fragmentation in safingol-treated cells. Mitochondrial membrane potential was decreased, and cytochrome c was released from mitochondria. However, the safingol-induced cell death was not accompanied by activation of caspase 3 and cleavage of poly (ADP-ribose) polymerase (PARP). The broad-spectrum caspase inhibitor BD-fmk failed to prevent safingol-induced cell death. Another apoptogenic factor endonuclease G, but not apoptosis-inducing factor (AIF), was also released from mitochondria and translocated to the nucleus. These results suggest that PKC α inhibitor safingol induces an endonuclease G- mediated apoptosis in a caspase-independent manner.


International Journal of Oral and Maxillofacial Surgery | 1998

Central acinic cell carcinoma of the mandible. Report of a case.

Mitsuhiro Nakazawa; Tetsuro Ohnishi; Souichi Iwai; Masayoshi Sakuda

Central acinic cell carcinoma is extremely rare; only six cases have been reported in the literature. An unusual case of central acinic cell carcinoma of the mandible in an 84-year-old Japanese woman is presented. This is thought to be the seventh case of central acinic cell carcinoma described in the English literature.


In Vitro Cellular & Developmental Biology – Animal | 1995

THE KINETICS OF INDUCTION OF HOX1.6 AND C-JUN MRNA DURING THREE DIFFERENT WAYS OF INDUCING DIFFERENTIATION IN TERATOCARCINOMA F9 CELLS

Souichi Iwai; Yukio Nishina; Mitsuko Kosaka; Tetsuro Sumi; Toshihide Doi; Masayoshi Sakuda; Yoshitake Nishimune

SummaryChanges in Hox1.6 and c-jun gene expression were examined upon F9 cell differentiation that was induced by three independent methods: a drug treatment with retinoic acid (RA), that with sodium butyrate (NaB), and a genetic approach using thets mutant. To obtain further information on the mechanism of teratocarcinoma cell differentiation we have examined the kinetics of the induction of Hox1.6 and c-jun mRNA whose gene products have been demonstrated to have specific roles in gene regulation. Expression of Hox1.6 mRNA was induced more rapidly than c-jun mRNA by all the above three inducing methods. Furthermore, protein synthesis was not required for the induction of Hox1.6 mRNA as well as of c-jun mRNA synthesis in all three methods. The data suggested that the transcriptional increase in the Hox1.6 mRNA was a primary response and could play an important role in F9 cell differentiation.


Cancer Letters | 1995

Induction of teratocarcinoma F9 cell differentiation with cis-diammine dichloroplatinum(II) (CDDP)

Toshihide Doi; Tetsuro Sumi; Yukio Nishina; Mitsuko Kosaka; Souichi Iwai; Masayoshi Sakuda; Yoshitake Nishimune

cis-Diammine dichloroplatinum(II) (CDDP) is the salt of a platinum compound which has been noted to have a wide spectrum of activity against malignant disorders. We have studied the effects of CDDP on embryonal carcinoma F9 cell differentiation. In the presence of this agent in vitro, the cells showed rapid morphological changes, a marked increase in the mRNA expression of various differentiation markers accompanied by a loss of tumorigenicity. These results indicate that the differentiation of F9 cells is induced with CDDP.


Cancer Letters | 2002

Induction of instability of p34cdc2 expression by treatment with cisplatin (CDDP) in mouse teratocarcinoma F9 cells

Toshihide Doi; Takashi Morita; Nobunao Wakabayashi; Tetsuro Sumi; Souichi Iwai; Shigeki Amekawa; Masayoshi Sakuda; Yoshitake Nishimune

p34(cdc2) is a protein kinase that plays an important role in the control of the cell cycle and regulation of activity of the tumor suppressor gene. Previously, we demonstrated that cisplatin (CDDP) induced growth suppression resulting in differentiation of teratocarcinoma F9 cells. In the present study, we investigated the mechanism of cell cycle retardation by CDDP in F9 cells, focusing on p34(cdc2). After the induction of differentiation with CDDP, F9 cells were arrested at the late S+G2/M. After treatment with CDDP, the level of the expression of cdc2 mRNA did not change. However, the half-life of p34(cdc2) was greatly reduced, thus, the level of p34(cdc2) protein was decreased. These findings suggest that the cell cycle arrest by CDDP is due partly to the induced instability of p34(cdc2) in F9 cells.


Journal of Oral and Maxillofacial Surgery | 1996

Desmoplastic fibroma of the mandible mimicking osteogenic sarcoma: Report of a case

Souichi Iwai; Ken Matsumoto; Masayoshi Sakuda


Experimental Cell Research | 1995

Effects of Protein Phosphatase Inhibition by Okadaic Acid on the Differentiation of F9 Embryonal Carcinoma cells

Yukio Nishina; Tetsuro Sumi; Souichi Iwai; Yoshitake Nishimune


Experimental Cell Research | 1993

The Induction of jun Genes during the Reversible Changes Induced with Sodium Butyrate on the Differentiation of F9 Cells

Yukio Nishina; Tetsuro Sumi; Souichi Iwai; Mitsuko Kosaka; Yoshitake Nishimune


Experimental Cell Research | 1993

Changes in Hox1.6, c-jun, and Oct-3 Gene Expressions Are Associated with Teratocarcinoma F9 Cell Differentiation in Three Different Ways of Induction

Souichi Iwai; Mitsuko Kosaka; Yukio Nishina; Tetsuro Sumi; Masayoshi Sakuda; Yoshitake Nishimune


International Journal of Clinical Pharmacology Research | 2005

Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.

Mitsuhiro Nakazawa; Ohnishi T; Masatoshi Ohmae; Chisoku H; Yui S; Souichi Iwai; Tetsurou Sumi; Fukuda Y; Mitsunobu Kishino; Yoshiaki Yura

Collaboration


Dive into the Souichi Iwai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge